Quantum Biopharma Ltd. submitted a Form 6-K on May 19, 2025, regarding its reporting obligations under the Securities Exchange Act. The filing indicates that the company files annual reports under Form 20-F.
AI Assistant
QUANTUM BIOPHARMA LTD
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.